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ABSTRACT 
Two commercial molecular assays, the PremiTest Salmonella and the xMAP Salmonella, 
were recently developed with the goal of identifying many of the most common 
Salmonella enterica serovars in less than eight hours. This study compared the results of 
these two assays to that of traditional serotyping on 233 isolates representing more than 
52 different serovars, including the ten most frequently identified at the NVSL from 2000 
to 2010. The PremiTest assay completely and correctly identified 150 isolates (64%) and 
the xMAP assay identified 181 isolates (78%). Both molecular assays were able to 
partially identify additional serovars. These assays offer a new, rapid approach to 
screening Salmonella isolates in the laboratory. 
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CHAPTER 1. REVIEW OF LITERATURE 
Salmonella is a genus of Gram-negative, rod-shaped, non-sporulating bacteria in the 
family Enterobacteriaceae. The salmonellae are facultative anaerobes that ferment 
glucose and are able to use citrate as a sole carbon source. They are motile by means of 
peritrichous flagella, with the exception of the non-motile Salmonella serovar Gallinarum 
[1-4]. The genus consists of two species; Salmonella enterica and Salmonella bongori. 
Each subspecies is designated with a Roman numeral as well as a name. Salmonella 
bongori (V) was originally considered a subspecies, so the original Roman numeral 
designation was kept to avoid confusion. Salmonella enterica is further divided into six 
subspecies; Salmonella enterica subspecies enterica (I), Salmonella enterica subspecies 
salamae (II), Salmonella enterica subspecies arizonae (IIIa), Salmonella enterica 
subspecies diarizonae (IIIb), Salmonella enterica subspecies houtenae (IV) and 
Salmonella enterica subspecies indica (VI) [3, 5]. Speciation is determined by the 
differences in abilities to utilize various chemical compounds for growth.  Salmonella 
enterica subspecies enterica serovars are found to cause over 90% of Salmonella 
infections in humans. Salmonella enterica subspecies salamae, arizonae and diarizonae 
are most often found in the intestines of reptiles and other cold blooded animals, although 
arizonae can be problematic in turkey poults and sheep [3]. Salmonella enterica 
subspecies houtenae and Salmonella bongori are most often found in the environment 
and are not typically pathogenic to man [6]. Salmonella subterranean was formerly 
considered to be a third species, but was recently determined to not belong to the genus 
Salmonella based on DNA relatedness studies [5]. Salmonella is ubiquitous and found 
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worldwide in water, dust, soil, insects, raw meat, poultry, eggs and seafood. Salmonellae 
are enteric pathogens of man and animals, particularly livestock and poultry. Various 
serovars have been found on surfaces of vegetables, feeds and fruits, likely due to fecal 
contamination [2, 6, 7]. They are able to survive and thrive in a wide variety of 
conditions, growing at temperatures ranging from 8-45°C, pH of 4-9, and in 
environments of up to a 20% salt concentration. They are resistant to drying and thought 
to survive in dust for years [2]. 
Salmonella serovar Typhi was first described in 1880 by Eberth. The first isolation of 
what would later be known as Salmonella serovar Choleraesuis, was made in 1885 when 
Theobald Smith, under the direction of Daniel Salmon, isolated what was believed to be 
the causative agent of hog cholera. They named their organism Bacillus Cholera-Suis [3, 
4, 8]. In 1900, the genus name of Salmonella was officially given by Lignères [4, 6]. The 
first serological testing of Salmonella occurred in 1896 when Gruber and Durham 
demonstrated the agglutination of typhoid bacterial cells by serum collected from patients 
with typhoid and from animals that had been inoculated with the typhoid bacteria [4, 9]. 
In 1903, Smith and Reagh described the differing reactions of the antigens of  
Salmonella, but their work was largely ignored at the time [1]. In 1918, Felix and Weil 
described the O and H antigens and Andrews found that Salmonella had two distinct “H” 
phases in 1922 [4]. White developed an antigenic scheme for typing of Salmonella in 
1926, and Kauffmann published a scheme in 1929 [1, 4].  In 1934, the scheme was 
updated, and the first official Kauffmann-White Schema was published. The World 
Health Organization Collaborating Centre for Reference and Research on Salmonella 
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(WHOCC-Salm) is responsible for maintaining the list of serovars, the validation of 
newly discovered serovars and for continuous update of the scheme containing more than 
2500 serovars. This scheme is considered the “gold standard” for typing of Salmonella 
and is used throughout the world [1, 3, 5, 6]. The Kaufmann-White scheme describes the 
antigenic formula that makes up a particular Salmonella serovar. In the case of 
Salmonella enterica subspecies enterica, a name is also given. The serovar is comprised 
of a Roman numeral to indicate the subspecies; the somatic (O) antigen; the first flagellar 
(H1 antigen) and the second flagellar (H2) antigen, if present. The O, H1 and H2 antigens 
are each separated by a colon [5].  
Salmonellosis is considered to be the most frequently occurring foodborne illness 
worldwide [2, 6, 8]. Illness from ingestion can present as enteritis, paratyphoid fever or 
typhoid fever. The human health impact and financial implications from infection with 
Salmonella are staggering. This burden is felt in both developed and non-developed 
countries. Developed countries tend to have high numbers of gastroenteritis infection due 
to the nature of commercially prepared food and food products [9, 10]. It has been 
estimated that there are between 2 to 4 million people that are infected with non-
typhoidal salmonellosis in the United States annually, with between 500-1000 deaths 
resulting from complications of infection. The financial burden associated with 
Salmonella in the United States alone is estimated to exceed 3 billion dollars annually [9, 
11]. Developing countries are more likely to experience the problems of typhoid and 
paratyphoid fevers due to issues of contaminated water sources [7]. World Health 
Organization (WHO) numbers estimate that there are approximately 16.6 million cases of 
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typhoid annually, and over 600,000 people die each year worldwide from Salmonella 
serovar Typhi [9]. Infectious dose can be as low as one cell and as high as 1 x 1012 cells, 
depending on the virulence attributes of the particular organism as well as the 
susceptibility of the host [2, 7, 12]. Some serovars of Salmonella are host adapted: 
Salmonella enterica serovar Dublin in cattle, Salmonella enterica serovar Gallinarum in 
poultry, and Salmonella enterica serovar Choleraesuis in swine are a few examples. 
Although these serovars are considered to be host adapted, all Salmonella can be 
pathogenic in man, and when these serovars cause infection in man, the disease tends to 
be severe and systemic. They often cause higher mortality rates, as they tend to occur in 
the very young, the elderly and the immune compromised.  Even very low numbers can 
cause significant disease in individuals who are more susceptible to infection.  Infants 
tend to be very sensitive to Salmonella infections and can experience severe 
complications such as mucopurulent bloody diarrhea leading to severe dehydration, 
toxicosis and meningitis [7, 13]. For the average individual, gastroenteritis symptoms 
begin within 6-72 hours after consumption of food containing a large number of 
organisms. Symptoms include abdominal cramping, nausea with occasional vomiting, 
diarrhea, fever, and headache. The disease is usually self-limiting, and lasts from 2-7 
days. Administration of antibiotics frequently prolongs shedding [2, 5, 7, 14]. Symptoms 
of typhoidal salmonellosis appear 1-4 weeks following ingestion of Salmonella serovar 
Typhi or Paratyphi organisms and include high fever, diarrhea or constipation, 
appearance of classical “rose spot” rash and extreme fatigue. If untreated, typhoid fever 
can have mortality rates as high as 10 to 15%. Disease usually lasts 2-4 weeks, although 
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an individual can continue shedding the organism for months and occasionally years [2, 
7, 8]. 
Salmonella is also a problem in animals. As is the case in humans, infections caused by 
Salmonella in animals can present at a subclinical level, where no signs of illness are 
present, but the animal maintains the infection and intermittently or continuously sheds 
the organism into its environment. Animals may exhibit signs of mild to severe enteritis 
and occasionally, a typhoid-like illness capable of causing systemic infection and death. 
Severe illness is most often associated with species-specific Salmonella serovars that 
occur in neonates or adult animals that are stressed from deprivation of food and water, 
poor nutrition, crowded conditions, periods of long transportation, illness and injury, or 
pregnancy. Often, infection with the same serovars in normal healthy adult animals tends 
to cause a mild to sub-clinical infection, but leaves the animal in a carrier state [15-19]. In 
poultry, Salmonella serovar Gallinarum var. Pullorum is associated with significant 
disease in young chicks. Many die prior to or just after hatching. Chicks that hatch 
exhibit a characteristic white diarrhea with pasting of the vent and ruffling of the feathers. 
Mortality is typically very high. Another biovar, Salmonella Gallinarum var. Gallinarum, 
is the causative agent of fowl typhoid. Fowl typhoid causes illness in all ages of poultry. 
Symptoms can include yellow diarrhea with mucus, depression, respiratory distress, 
decreased egg production and sporadic death [16, 19-21]. Salmonella enterica subspecies 
arizonae can cause significant problems in turkey poults less than 3 weeks of age with 
mortality rates of up to 80%. Symptoms include diarrhea, pasting of the vent, anorexia, 
listlessness, ruffled feathers and shivering. Those that do survive typically become long 
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term carriers. Adults typically are asymptomatic although a decrease in egg production 
can occur and they tend to shed the organism for long periods of time [15, 22]. 
Salmonella serovar Typhimurium and Salmonella serovar Dublin both cause clinical 
disease in calves, however, Salmonella serovar Typhimurium tends to cause significant 
illness in calves less than one month old, whereas Salmonella serovar Dublin becomes 
problematic in calves that are between two and three months old. Symptoms include 
watery diarrhea with mucus or blood present, fever, dehydration, sepsis, pneumonia, and 
moist cough. Losses can be very high, and death can occur shortly after signs develop.  
Adult cattle occasionally develop mild enteritis, pregnant cows may abort, and milk 
production can decrease. Adults tend to shed Salmonella for months to years, especially 
in times of stress [15, 23-25]. Salmonella infections in adult swine are not common, and 
typically can be traced to the purchase of an infected animal. Salmonella serovar 
Typhimurium is known to cause diarrhea, anorexia, and fever in young piglets, although 
mortality is not high. Salmonella serovar Choleraesuis can infect swine of all ages. Swine 
present with fever, anorexia, depression and respiratory distress leading to cyanosis; 
mortality from infection can be quite high [15, 26]. Salmonella infections can cause 
problems in equines of all ages. Salmonella serovar Abortusequi is a causative agent of 
abortion in pregnant mares and was first described in 1893. Other Salmonella serovars 
can persist in the mare without detection throughout pregnancy, and the stress of foaling 
can cause sudden shedding with the foal being infected during or immediately after birth. 
Salmonella infection in foals tends to be systemic, with signs of depression, fever, and 
severe diarrhea leading to dehydration and electrolyte imbalance. Endocarditis, 
pneumonia, meningitis and infection of the joints can also occur. Mortality can be high. 
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Salmonella is also a significant issue in hospitalized horses of all ages [15, 18, 27]. 
Typically, Salmonella infections in dogs and cats are uncommon, however, there have 
been infections that have been traced back to dry pet food in recent years [28]. Younger 
puppies and kittens are more likely to become ill from Salmonella, and mortality is very 
low, although carrier status may last for several weeks. Typical signs are gastroenteritis, 
fever and lethargy [15, 29].  
The ability of Salmonella to survive in many different environments and produce a 
carrier state in relatively healthy humans and animals presents a significant challenge for 
the control of infection. This contributes significantly to the problem of foodborne 
disease on many levels. Ideal control includes removal of diseased animals from the food 
chain; however, it is not easy to identify carrier animals when they appear asymptomatic. 
As apparently healthy carriers leave the farm for slaughter, the conditions of crowding, 
withholding of feed and transport cause stress to the animal. As they are being 
transported, the stress of this leads to the shedding of Salmonella into the environment 
from animals that have shown no visible sign of infection. The close proximity allows 
previously unexposed animals to become infected or physically contaminated.   
Meat and poultry inspection processes work to protect consumers by providing pre- and 
post-mortem inspection of animals, prevention of diseased meat from entering into the 
food chain, continuous inspection of products through processing, and setting guidelines 
for strict hygiene within the processing plant environment to prevent contamination. The 
United States first passed federal legislation on meat inspection in 1890 which was 
followed by the Meat Inspection Act of 1906. This was regulated by the USDA’s Animal 
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Inspection Agency under Dr. Daniel Salmon. The Poultry Products Inspection Act passed 
by Congress in 1957 provided similar guidelines for the inspection of poultry and poultry 
products. Many of the standards of these acts are still in use today  [30, 31]. 
 Surveillance and inspection programs help to track the occurrence of Salmonella, as well 
as the changes that occur over time with the goal of identifying potential hazards or 
critical points in which Salmonella contamination can enter the farm-to-fork chain of 
food production.  Programs such as Foodborne Diseases Active Surveillance Network 
(FoodNet), which include both public health organizations such as the Centers for 
Disease Control (CDC), state health laboratories, and the Food and Drug Administration 
(FDA) as well as veterinary organizations like the United States Department of 
Agriculture’s (USDA)-Food Safety Inspection Services (FSIS)  and the USDA-Animal 
and Plant Health Inspection Services (APHIS), collaborate to actively track laboratory 
confirmed cases of Salmonella. It is critical that both human health and veterinary 
diagnostic laboratories work together, as animals are the principal vectors of zoonotic 
salmonellosis [7, 32, 33]. Any animal or animal product can potentially be infected with 
or become contaminated with Salmonella. Some serovars are able to better survive and 
thrive than others, and although most serovars have the potential to cause disease in man, 
five to ten account for the majority of cases of salmonellosis that are seen in both man 
and animals [34, 35]. Salmonella serovar Enteritidis has been linked to many human 
health outbreaks and most often is associated with poultry and eggs. Hens are often 
infected without any visible sign, and can be laying eggs that harbor the bacterium. 
Salmonella serovar Enteritidis infections in humans can often be traced back to 
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contaminated shell eggs that are served ‘sunny-side-up”, soft boiled or lightly scrambled 
or have been used in foods that are not cooked or are undercooked [2, 7, 16, 19, 36]. 
Programs such as the USDA’s National Poultry Improvement Plan (NPIP) and the FDA’s 
shell egg program were established to decrease the prevalence of Salmonella in both 
poultry and in shell eggs on the farm through regulations that include implementation of 
biosecurity programs, incorporation of measures to control insects, rodents and wild bird 
access, hygienic disposal of animal wastes, ensuring that feed and water are free from 
Salmonella, proper disinfection procedures, monitoring of the environment and testing of 
animals and eggs for the presence of Salmonella. These agencies also define rules for 
diversion of eggs and culling of flocks as well as disinfection procedures if monitoring 
samples show that Salmonella serovar Enteritidis is present [19, 36, 37].  
Salmonella serovars Typhimurium, Enteritidis, Heidelberg, Montevideo, Newport, 
Javiana and 4,(5),12:i:- were recognized as serovars that cause up to 64% of  illness in 
man. These serovars are most often found on carcasses of chicken, turkey, cattle and 
swine, and in ground beef, ground turkey and ground chicken [12, 19, 22, 25, 26, 34, 38]. 
FSIS implemented the Pathogen Reduction; Hazard Analysis and Critical Control Point 
(HACCP) Systems in 1996 which established performance standards for the prevalence 
of Salmonella in facilities that slaughter animals or those that produce raw meats or raw 
ground products. These standards are based on the number of samples per set that are 
positive for Salmonella, as opposed to the number of organisms that are present. The 
number of samples and the number of positives allowed for each set are based on the 
class of product. Updates to the rule were made in 2006 and 2008 which focus on the 
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prevalence of serovars of Salmonella that are of human health concern as part of the 
surveillance process. When considering the number of positive samples that are 
considered acceptable, only a percentage of those can be of serovars of public health 
significance. Facilities that are not able to maintain consistently low numbers of 
Salmonella and serovars that are most likely to cause foodborne illness in man are subject 
to additional surveillance by FSIS [12, 38].  
Identification of Salmonella serovars in animals, their environment, meat, eggs and other 
food products provides critical information for surveillance, status of a herd, the 
successes of manufacturing processers to control the spread of pathogens, and 
epidemiology in the event of foodborne illnesses. For more than 70 years, classical 
serotyping of Salmonella has been performed using standardized animal antisera to test 
for the lipopolysaccharide (O antigen) and the flagellar proteins (H antigens) in 
accordance with the methods described by Kauffmann and White. The scheme, which 
was first published in 1934, is still utilized throughout the world and contains over 2500 
different serovars [1, 3, 8]. Although classical serotyping is considered to be the “gold 
standard” of testing, there are several disadvantages. Because classical serotyping is 
dependent upon phenotypic expression of the O and H antigens, those isolates that 
express a rough O antigen or have lost the ability to express one or both flagellar antigens 
are not able to be completely typed. Fimbriated and encapsulated strains also mask the 
phenotypic expression of the O antigens [3]. Laboratories that wish to test for the 2500 
plus serovars of Salmonella are required to maintain more than 160 different antisera. 
Commercial antisera are available for the most commonly typed Salmonella antigens, 
11 
 
however, the sera can be expensive and extensive quality control with a wide variety of 
Salmonella serovars must be performed to assure that the sera are reacting as expected. 
Several additional antisera are not commercially available, which limits the abilities of 
many laboratories to the testing of only the most common serovars of Salmonella. 
Complete characterization of isolates for which sera are not available requires that they 
must be forwarded to a reference laboratory that is able to produce additional antisera in-
house. Production of standardized antisera in laboratory animals and the subsequent 
absorptions take time and are costly to produce.  Only a small number of laboratories 
have these capabilities. Classical serotyping must be performed by staff who are 
adequately trained and the time required to perform testing can take several days to more 
than a week [3, 8, 39, 40]. Rapid identification is essential when surveillance on the farm 
indicates that a serovar such as Salmonella serovar Enteritidis may be present so that 
animals or animal products containing serovars of consequence to public health are 
identified and excluded from the food chain.  Compliance with regulations put forth by 
FSIS require that results are provided in a timely manner to assist in the identification of 
contaminated products [36-38]. In order to meet the needs of these regulations, several 
assays have been developed with the goal of obtaining rapid identification of Salmonella 
serovars of human and veterinary significance. Alternative approaches for replacing 
classical serotyping include pulsed field gel electrophoresis (PFGE), antibody based 
microarrays, Multilocus Variable number of tandem repeats Analysis (MLVA), 
Multilocus Sequence Typing (MLST), PCR, real-time PCR, and DNA sequencing [8, 20, 
21, 39-44]. PFGE is considered the “gold-standard” of molecular finger-printing for 
epidemiological studies, as it is able to identify genomic differences among strains of the 
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same serovar. However, not all serovars of Salmonella show significant genetic diversity 
on PFGE, including Salmonella serovar Enteritidis. Other serovars show significant 
diversity from isolate to isolate. PFGE requires expensive specialized software to analyze 
results as well as an extensive database containing the patterns of many isolates. Few 
laboratories are able to maintain such databases. When a pattern is found that does not 
match those in the database, additional testing is required. PFGE is also very labor 
intensive, and less than 15 isolates can be analyzed on a standard gel [8, 45]. An antibody 
based microarray that is able to identify 20 common Salmonella serovars has been 
described. While the assay is able to test for multiple Salmonella antigens at the same 
time, thus decreasing testing time, it also requires the use of commercially available 
antisera and is dependent upon the phenotypic expression of the surface antigens of 
Salmonella [46]. Many PCR and Real-Time PCR’s have been developed for the rapid 
identification of Salmonella serovars; however, they are typically developed to target one 
to a handful of serovars. These assays can be useful for laboratories that are performing 
testing for specific serovars in surveillance programs, such as Salmonella serovar 
Enteritidis in shell egg production. MLST aims to identify genetic relationships within 
and between serovars through automated DNA sequencing of internal fragments of 
multiple housekeeping genes. Current assays have only considered a few different 
serovars of Salmonella.  Like PFGE, databases to compare results are necessary, and the 
cost of DNA sequencing will exclude most laboratories from the technology [8, 47, 48]. 
The ideal assay to incorporate into a laboratory that is performing serotyping will be easy 
to implement while providing a rapid, accurate result. To be cost effective, it must cover 
a broad range of serovars, be able to test multiple isolates at one time and the cost of the 
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equipment and consumables must be reasonable. The results should be easily defined and 
consistent with the Kauffmann-White scheme, as that is the “gold-standard” of 
Salmonella serotyping. The PremiTest Salmonella (PTS) is a commercially available 
multiplexed DNA assay that was designed to type the most common serovars of 
Salmonella. The PTS selects for genetic markers that are designed to provide unique 
hybridization profiles for common Salmonella enterica subspecies enterica serovars 
through a process known as multiplex ligation detection reaction (LDR).  Typing is based 
on a set of 14 LDR probes which target genetic markers that differ in the various serovars 
of Salmonella. Each LDR probe contains a unique “ZIP-code.” The LDR probes generate 
circular fragments of DNA from an isolate, which are then amplified through PCR. The 
amplified products are biotinylated during PCR. Following PCR, the amplified probes are 
then hybridized onto a low density microarray tube embedded with 100 complementary 
“cZIP-code” oligonucleotides. Conjugation of biotinylated products is performed with 
streptavidin-horseradish peroxidase, the conjugate is rinsed away, and a peroxidase 
substrate is added to provide staining of bound products. Microarray tubes are analyzed 
with a photometric detector using proprietary software. Because there are multiple steps 
to the assay, controls have been built into the array tube to indicate success of each step:  
probe ligation specificity and efficiency, PCR amplification, efficiency of hybridization, 
detection of the label and the quality of the label. If results indicated assay failure, the 
controls provide information indicating where the failure occurred. Only the failed steps 
need to be repeated. The microarray tube is designed to allow three separate isolates to be 
analyzed at a time.  
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The PTS assay was tested in parallel with classical serotyping on 754 isolates 
representing 58 serovars of animal origin from Belgium and the Netherlands in 2007 by 
Wattiau et al. as directed by the manufacturer on the ATR-03 using CheckPoints software 
version 4.2 [43]. The DNA was extracted for the subsequent reactions using the provided 
reagents according to the procedure outlined by the manufacturer. Correct identifications 
were obtained for 658 isolates (87%), 23 samples (3%) had assay failures, 50 isolates 
(7%) identified unique genovar codes, 16 isolates (2%) gave dual results, and 7 isolates 
(1%) gave incorrect identifications. Classical serotyping identified 685 isolates (91%) 
completely. The remaining 69 isolates (9%) were not completely typed because of rough 
O antigen or lack of expression of one or both H antigens. The authors found that when 
assay failures were observed, they most commonly occurred with three serovars; 
Salmonella serovar Typhimurium, Salmonella serovar Infantis and Salmonella serovar 
Paratyphi B var. Java. Seven identification errors were observed: Salmonella serovar 
Anatum was incorrectly identified as Salmonella serovar Newport, Salmonella serovar 
Borreze was misidentified as Salmonella serovar Agona, Salmonella serovar Regent was 
incorrectly identified as Salmonella serovar Altona or Salmonella serovar Agona, 
Salmonella serovar SanDiego was incorrectly named Salmonella serovar Muenster, 
Salmonella serovar Virchow was misidentified as Salmonella serovar Minnesota, and two 
isolates of Salmonella serovar Weltevreden were incorrectly typed as Salmonella serovar 
Brandenburg. Another isolate that was incomplete due to lack of flagellar antigen 
expression on classical serotyping had the antigenic formula of 9,46:-:-. The PTS 
identified this isolate as Salmonella serovar Enteritidis. Salmonella serovar Enteritidis 
does not express O factor 46. Assuming that classical typing of the O antigen is correct, 
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this isolate would also be incorrectly identified on the PremiTest assay [3, 5]. The authors 
of this study chose to re-analyze problematic isolates using a purified DNA extract in 
place of the crude bacterial extract that was described in the assay protocol. Correct 
identification of 714 isolates (94.4%) was achieved with the use of this DNA for testing. 
All of the results from assay failure were resolved. The error rate decreased as well: one 
isolate of Salmonella serovar Anatum that had been misidentified as Salmonella serovar 
Newport, was correctly identified on retesting and the isolate of Salmonella serovar 
SanDiego which had been incorrectly identified as Salmonella serovar Muenster gave a 
dual result of Salmonella serovar Muenster or Salmonella serovar SanDiego when further 
analyzed using a purified DNA extract. The other five serovars (0.6%) that were 
described above still gave incorrect results with the second DNA extract.  
Meneses also compared the PremiTest assay with classical serotyping. One-hundred 
reference isolates and 100 isolates that were obtained from poultry and swine operations 
during the study were tested. Of the 200 isolates tested, 168 had serovars that were 
included in the PTS database. Of those, 105 isolates (63%) were correctly identified and 
comparable to the results observed from classical serotyping, 45 (27%) were inconclusive 
due to assay error, dual results or unique genovar identifications, and 18 (10%) had 
incorrect serovar names assigned. Salmonella serovar Agona and Salmonella serovar 
Collindale were both incorrectly identified as Salmonella serovar Montevideo, another 
isolate of Salmonella serovar Agona was misidentified as Salmonella serovar Altona, two 
isolates of Salmonella serovar Branderup were incorrectly identified as Salmonella 
serovar Manhattan, Salmonella serovar Derby was incorrectly designated  Salmonella 
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serovar Adelaide, two isolates of Salmonella serovar Enteritidis were also incorrectly 
identified, one as Salmonella serovar Hadar and the other as Salmonella serovar 
Heidelberg. Salmonella serovar Fresno was misidentified as Salmonella serovar Ouakam 
or Salmonella serovar Meleagridis. Salmonella serovar Litchfield and Salmonella serovar 
Tennessee were also incorrectly identified as Salmonella serovar Ouakam. An isolate of 
Salmonella serovar Infantis was incorrectly named Salmonella serovar Heidelberg, 
Salmonella serovar Kentucky was incorrectly identified as Salmonella serovar Ohio, 
Salmonella serovar Livingstone was misidentified as Salmonella serovar Lille, 
Salmonella serovar Montevideo was incorrectly named Salmonella serovar 
Schwarzengrund or Salmonella serovar Grumpensis, Salmonella serovar Muenchen was 
incorrectly identified as Salmonella serovar Newport, Salmonella serovar Oranienburg 
was incorrectly identified as Salmonella serovar Monschaui, Salmonella serovar Stanley 
was misidentified as Salmonella Muenchen, and Salmonella serovar Worthington was 
incorrectly named Salmonella serovar SanDiego. Thirty-two isolates were not included in 
the PTS database and were not expected to give serovar results; however, 13 isolates 
were incorrectly identified. Salmonella serovar Alachaua was incorrectly identified as 
Salmonella serovar Cubana, Salmonella serovar Cape was incorrectly identified as 
Salmonella serovar Thompson, Salmonella serovar Essen was misidentified as 
Salmonella serovar Derby, Salmonella serovar Fresno was incorrectly identified as 
Salmonella serovar Ouakam or Salmonella serovar Meleagridis, Salmonella serovar 
Gaminara was misidentified as Salmonella serovar Typhimurium, Salmonella serovar 
Menston was incorrectly identified as Salmonella serovar Oranienburg, Salmonella 
serovar Remo was incorrectly named Salmonella serovar Schwarzengrund or Salmonella 
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serovar Grumpensis, Salmonella serovar Thomasville was incorrectly identified as 
Salmonella serovar Orion, Salmonella serovar Try was incorrectly identified as 
Salmonella serovar Typhimurium, two isolates of Salmonella serovar Johannesburg were 
misidentified as Salmonella serovar Urbana, and Salmonella serovar Menhaden and 
Salmonella serovar New Brunswick were both incorrectly identified as Salmonella 
serovar Give [33].  
The Luminex Multianalyte Profiling Salmonella serotyping assay (xMAP-SSA) is a 
multiplexed, nucleic acid-based array that was designed to serotype Salmonella isolates 
based on the genetic markers that determine the O and H antigens. Following a simple 
DNA extraction, individual PCR reactions are performed for the O and H antigens. The O 
antigen assay primers are designed to amplify specific genes in the rfb region which are 
responsible for the genetic variations among the individual serogroups. Specific primer 
and probe sets were designed for each of the serogroups O13, B, C1, C2, D, and E and 
for Salmonella serovar Paratyphi A. The forward primers for the O antigen assay were 
biotin labeled at the 5’ end.  The H antigen assay contains nine forward primers and 11 
reverse primers that are designed to amplify the variable regions of the fliC (H1) and fljB 
(H2) genes. The 5’ ends of the reverse primers were biotin labeled for the H antigen 
assay. The O and H antigen oligonucleotide probes were covalently linked to individual 
microspheres that were internally dyed with varying concentrations of red and infrared 
fluorophores. The specific concentrations of the dyes give each bead a “color” that is then 
associated with a unique spectral address. Each assay consists of a panel of O or H 
antigen-specific probes linked to one of 100 differently “colored” beads.  Following 
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amplification, the biotinylated PCR products are transferred to a 96-well plate containing 
the labeled O or H bead sets for hybridization. After binding to the probe-labeled beads, 
the reporter dye, Streptavidin-Phycoerythrin (SAPE) is added to the reaction. The 96-well 
plate is placed into the BioRad LX200 for sampling and data acquisition. A sample is 
drawn up from each well through a flow cytrometry-based system, and the linked 
microspheres pass through the detection chamber. Each bead is individually analyzed by 
two lasers. The first laser excites the fluorescent dye of the microsphere and classifies it 
according to its unique spectral address. The reporter laser analyses the signal and 
reporter dye content from beads to detect the presence of covalently bound probes that 
are hybridized to biotinylated PCR products. The results are reported as median 
fluorescence intensity (MFI) which is automatically calculated in the LX200 software. A 
positive signal is defined as an MFI giving 6 times the background signal [39, 40]. 
Fitzgerald et al. described the development and validation of the O antigen assay [40]. 
The assay was tested on a panel of 393 isolates of Salmonella that were obtained from the 
culture collection of the Salmonella Reference Laboratories at the Centers for Disease 
Control and Prevention. Results were compared to classical typing. Classical serotyping 
was able to type the O group for 384 isolates (98%). Nine isolates produced a rough O 
result with classical serotyping. Molecular typing was able to identify 368 of the 393 
isolates (94%). Six of the isolates that were considered rough by classical serotyping 
were successfully typed on the xMAP Salmonella assay. Seventeen isolates (4.4%) 
produced results that were different from classical serotyping but correlated to known 
genetic relationships between O antigens that are not observed with classical serotyping. 
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Five isolates (1.3%) did not react with probes that were covered in the assay: two isolates 
of Salmonella bongori (V) and three isolates of Salmonella enterica subspecies 
diarizonae (IIIb) did not react with O13. 
McQuiston et al. described the development and validation of the H antigen assay [39]. 
The assay was evaluated on a panel of 500 isolates of Salmonella obtained from the 
culture collection of the Salmonella Reference Laboratory at the Centers for Disease 
Control and Prevention. Testing was performed in parallel with classical serotyping. The 
H antigen assay was able to completely type 402 of the 500 isolates (80%). Forty-six of 
the 500 isolates (9%) were partially serotyped, but contained an H1 or H2 antigen that 
was not in the assay. The H antigen assay was able to correctly type 13 isolates (3%) that 
were untypeable by classical serotyping because of lack of expression of one or both H 
antigens. Thirty-nine isolates (8%) did not react with probes that were covered in the 
assay. Twenty-five of the 39 isolates did not react to the H:5 or H:t probes. It is known 
that there are multiple genetic lineages for both single factor 5 and single factor t. The 
bead for the single factor t in the assay represents one of three possible lineages. The 
bead for the single factor 5 represents most, but not all, lineages. Six isolates of 
Salmonella enterica subspecies diarizonae (IIIb) did not react with the H:z probe, one 
subspecies IIIb isolate did not react with the H:z35 probe. One isolate of Salmonella 
enterica subspecies salamae (II) did not react with the H:5 or H:7 probes, and one 
subspecies II isolate did not react with the H:x or H:z15 probes. Two isolates of 
Salmonella serovar Pensacola did not react with the H:m;m,t probe, two isolates of 
20 
 
9,12:l,v:- did not react with the H:v probe and one isolate of Salmonella serovar Putten 
did not react with the H:d probe. There were no incorrect results. 
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CHAPTER 2. INTRODUCTION 
Salmonella is one of the leading causes of food-borne illnesses accounting for an 
estimated 93.8 million cases and 155,000 deaths worldwide annually [6]. As infections 
increase, serotyping continues to be used as the definitive method of identification of the 
etiological agent and epidemiology. The genus Salmonella is comprised of two species: 
Salmonella enterica and Salmonella bongori. Salmonella enterica consists of six 
subspecies and can be further differentiated into more than 2500 serotypes. Salmonella 
serotypes are determined by specific patterns of reactions of their surface antigens with 
specific Salmonella antisera. 
Classical antiserum based serotyping using the Kaufmann-White scheme has been the 
standard method of serotyping Salmonella for epidemiological and monitoring purposes 
for more than seventy years. Classical serotyping relies on the phenotypic expression of 
the somatic lipopolysaccharide (O antigen) and the flagellar proteins (H antigens) of 
salmonellae. However, serological testing has several disadvantages, such as the use of 
more than 160 different antisera to test for the 2,500 plus serotypes of Salmonella. While 
standardized antisera are available for common antigens, there are many others that are 
not commercially available. Thus, most reference laboratories are required to produce 
significant volumes of in-house reagents in order to offer complete typing of Salmonella. 
Production of standardized antisera in laboratory animals and the subsequent absorptions 
take time and are costly to produce.  Additional issues that are commonly encountered 
during serotyping of Salmonella include: rough colony variants, leading to an 
indistinguishable O antigen; isolates that have lost the ability to express one or more 
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flagellar antigens; fimbriated strains; encapsulated strains; and isolates that express 
atypical biochemical reactions. The objectivity of the test requires that staff be 
extensively trained to assure accurate and reproducible results. Finally, the time required 
to test for complete serovar identification can take several days to more than a week. 
From 2000 to 2010, the United States Department of Agriculture (USDA), National 
Veterinary Services Laboratories (NVSL) Salmonella Reference Laboratory analyzed 
217,627 isolates submitted for serotyping. Twenty serovars accounted for 74% of all 
isolates that were serotyped at the NVSL during this interval.  Typing 18,000-20,000 
isolates per year requires a significant amount of time. As surveillance, monitoring, and 
control programs increase in the agriculture and food industries, the necessity for a faster, 
reliable test to identify the serovars of public health significance has become paramount. 
The objective of this study was to evaluate the potential of high-throughput, real-time 
molecular typing to replace or augment classical typing at the NVSL. Whereas classical 
serotyping relies on the phenotypic expression of surface antigens, DNA-based assays 
utilize stable genetic signatures. Several molecular assays have been developed and used 
for specific monitoring and surveillance programs; however, the vast majority of those 
tests can identify only a few serotypes. When considering the molecular assays currently 
available, this study looked at tests that would identify as many serovars as possible 
while maintaining the sensitivity and specificity of classical serotyping. Cost, time and 
technical skills necessary to perform the tests and interpret the results were also 
considered.  
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The PremiTest Salmonella (PTS) and the Luminex Multianalyte Profiling Salmonella 
serotyping assays (xMAP-SSA) represent two commercially available formats. The PTS 
is designed for rapid molecular serotyping by the recognition of highly specific DNA 
targets [43, 49]. A series of ligated probes are generated from genomic DNA, amplified 
by a polymerase chain reaction (PCR), and hybridized to a DNA microarray with specific 
primers, one of which is biotin labeled. Amplified biotinylated products are then detected 
on a photometric detector and analyzed using the proprietary software. Individual 
serovars are assigned a unique zip code based on a pattern of hybridizations that are 
produced in the micro-array tube. The assay was initially validated with 443 veterinary 
strains from Belgium and The Netherlands. A second study evaluated an additional 754 
veterinary strains from Belgium [43, 49]. 
The xMAP Salmonella serotyping assay is a system for determination of a serovar based 
on DNA markers that encode for specific O and H antigens. By using these markers, the 
xMAP assay amplifies target genes encoding the same antigens that the Kaufmann-White 
scheme utilizes, thus allowing for direct comparison of the results of a high-volume assay 
to that of classical serotyping. This provides the unique ability to tie partial results 
obtained by the assay back into classical testing to complete the serotyping when a 
particular antigen is not available in the test. The O assay was validated on a panel of 393 
strains and the H assay was validated on a panel of 500 strains [39, 40]. 
Ultimately, the PTS and the xMAP Salmonella assays were chosen for this study based 
on each manufacturer’s data which suggested that each assay identified more than 50 
different serotypes. 
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CHAPTER 3. MATERIALS AND METHODS 
Isolates. All isolates were obtained from the reference collection at the NVSL. Isolates 
were originally submitted to the Salmonella Reference Laboratory for identification or 
confirmation of serovar by state or private laboratories where the isolates were recovered 
from various animal and environmental sources.  A minimum of 5 isolates for each of the  
top 20 most commonly identified serotypes from all animal sources received at the NVSL 
for the time period of 2000-2010 were chosen for testing along with other serovars of 
significance to the animal industry. When multiple strains of the same serotype were 
selected, isolates from different geographical regions and different animal species were 
chosen, if possible, to reduce the likelihood of testing clonal strains.  
 In all, 233 isolates representing 52 serovars, 11 isolates not expressing one or more 
flagellar antigens, 1 isolate that contained multiple serotypes and 7 rough isolates were 
analyzed (Tables 1 and 2).   
Isolates chosen for testing on the xMAP Salmonella assay and the PremiTest Salmonella 
assay were assigned unique numbers and tested without the knowledge of their prior 
identification by classical serological testing. 
Classical serological testing. Isolates were serotyped utilizing the method described by 
Edwards and Ewing [3]. Commercial (Becton, Dickenson and Company, Sparks, 
Maryland; Remel, Dartford, England; Staten Serum Institute, Copenhagen, Denmark) and 
in-house prepared antisera were used for typing, as described [3]. Briefly, somatic 
antigen was prepared by washing the bacterial growth (16-20 hours at 37°C) off of the 
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bottom half of a blood agar slant with 1mL of 0.85% saline. Ten microliters of antigen 
and 10µL of antisera were mixed together on a glass slide and gently rocked for 1-2 
minutes after which agglutination was scored. All antigens were tested against a 
minimum of two antisera; most were tested against O groups B, C1, C2, D and E. 
Following determination of the somatic group, individual factors were tested as 
appropriate.  
To produce the flagellar antigen,  a tube containing 5mL of trypticase soy broth with 
tryptose was inoculated with an isolate and incubated ( 16-20 hours at 37°C) after which 
approximately 20mL of 0.85% saline containing 0.6% formalin was added. The antigen 
was allowed to sit for a minimum of one hour at room temperature following 
formalization. One milliliter of formalinized antigen was added to a 13x100 test tube 
containing 25µL of antisera and incubated (50°C water bath for 30 to 60 minutes). In 
instances where a complex antigen was detected, the individual components of the 
complex were then tested using 0.5mL antigen against 25µL of corresponding antisera 
and incubated, as previously described. Serovars were designated according to the 
antigenic composition listed in the Kauffmann-White Scheme based on the reactivity to 
individual antisera [3, 5]. 
PremiTest Salmonella assay. The PremiTest Salmonella kit was obtained from Check-
Points (Wageningen, The Netherlands). All of the required components and reagents for 
the test were included in the kit.  Procedures were followed strictly according to included 
protocol from the manufacturer. For DNA extraction, isolates were streaked onto nutrient 
agar plates and incubated (37°C for 16-20 hours). A single isolated colony was sampled 
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by inserting a toothpick directly into a colony, inoculating it into 100 µL lysis buffer and 
heating (15 minutes at 400 rpm at 99°C) in a Thermo-Mixer (Eppendorf, Hamburg, 
Germany). For PCR amplification, 10 µL of DNA extract was added to a strip tube 
containing 2.5 µL thawed dye solution and 5 µL Solution A. The sample was heated  
(95°C for 3 minutes), followed by 24 cycles each of denaturation (30 seconds at 95°C), 
primer extension  (5 minutes at 65°C), and a final step of 2 minutes at 98°C in a C1000 
Thermocycler (BioRad, Hercules, CA). Fresh B mix solution was made, and 15 µL was 
added to the tube, which was then was heated to 37°C for 45 minutes, and then to 95°C 
for 10 minutes. Fresh C mix (15 µL) was added to the tube, heated (95°C for 10 minutes), 
followed by 35 cycles each of denaturation (95°C for 5 seconds),  primer annealing (55°C 
for 30 seconds) and primer extension ( 72°C for 30 seconds), with a final incubation of 
95°C for 2 minutes.  Detection was carried out using the ArrayTube embedded with 
multiple oligonucleotide control spots which measure the efficiency of critical steps and a 
series of 14 specific ligation detection reaction (LDR) probes [43, 49] (Clondig, Jena, 
Germany) supplied in the PTS kit.  Hybridization buffer (300 µL) was added to the 
ArrayTube and preheated to 50°C in the Thermo-Mixer.  Amplified sample (10 µL) was 
added to the tube, incubated (50°C for 30 minutes at 400 rpm) and followed by a wash 
with 300 µL of blocking buffer (50°C for 5 minutes at 400 rpm). Blocking buffer was 
replaced with 300 µL of fresh blocking buffer, the temperature of the Thermo-Mixer was 
decreased to 30°C, and the tube was then incubated (10 minutes at 400 rpm).  Fresh 
conjugate was prepared by adding 5 µL of conjugate solution with 495 µL of detection 
buffer. Blocking buffer was removed from the array tube, and 150 µL of conjugate was 
added to the tube and incubated (15 minutes at 30°C at 400 rpm). Conjugate was 
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removed, replaced with 600 µL of detection buffer, and the tube was incubated (30°C at 
400 rpm for 2 minutes). Detection buffer was decanted, replaced with 600 µL of fresh 
detection buffer, and incubated (2 minutes at 30°C and 400 rpm). Finally, detection 
buffer was removed and 150 µL of staining solution was added to the array tube, and 
incubated (room temperature for 15 minutes). DNA hybridization results were analyzed 
after 15 minutes on the ATR-03 (Clondig, Jena Germany) using Check-Points software 
version 7.1. 
xMAP Salmonella serotyping assay. For DNA extraction, isolates were inoculated to 
blood agar base slants and incubated (37°C overnight). An inoculating needle was used to 
transfer a small amount of growth into a 0.2 µL PCR tube containing 25 µL of Instagene 
Matrix (Bio-Rad, Hercules, California) and vortexed for 30 seconds. Tubes were 
centrifuged  (2000 x g, 10 sec), placed in a C1000 Thermocycler (Bio-Rad, Hercules, 
California) and heated at 56°C for 10 minutes and 100°C for 5 minutes. Tubes were 
removed, 75 µL of nuclease-free water was added to each sample, tubes were vortexed 
for 30 seconds and then centrifuged (2000 x g, 5 minutes). The supernatant was carefully 
removed from the pellet and used as the DNA template for the PCR. For amplification, 
custom PCR primers were synthesized (Integrated DNA Technologies, Coralville, Iowa) 
according to the sequences described [39, 40].  Three PCR master mixes containing Taq 
polymerase, primers, dinucleotide triphosphates, magnesium chloride and water were 
prepared for each of the three typing assays: the O antigen assay; the H antigen assay; 
and the alternative targets (AT) assay. To provide for uniformity among the samples, 
each master mix was prepared in a 2 mL tube.  Each reaction consisted of 12.5 µL of 
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Qiagen HotStar Taq Mastermix, (Qiagen, Valencia, California) 2.5 µL of appropriate 
primer pool, and 8 µL of nuclease-free water. 23 µL of each master mix was pipetted into 
0.2 µL reaction tubes to which was added 2 µL of sample DNA, for a total of 25 µL per 
tube. Two µL of nuclease-free water served as the no-template control; 2 µL of DNA 
from a known isolate of Salmonella serotype Enteritidis was used as a positive control. 
Tubes were vortexed for 15 seconds and then briefly centrifuged (2000 x g) to remove 
any fluid from the tops of the tubes. Tubes were placed in the BioRad C1000 
Thermocycler and the assay was run under the following parameters: an initial cycle of 
heating (95°C for 15 minutes) to activate the Taq polymerase, followed by 30 cycles each 
of denaturation (94°C for 30 seconds), primer annealing (48°C for 90 seconds), and 
primer extension (72°C for 90 seconds) and a final incubation at 72°C for 10 minutes. 
For the hybridization reaction, oligonucleotide probes, specific to a particular Salmonella 
marker, were synthesized and covalently linked to polystyrene microspheres each 
containing a unique fluorescent spectral address (Radix, Georgetown, Texas), as 
described [39, 40]. The bead mixes were stored at 4°C in the dark, at a concentration of 
2.5 x106 microspheres per mL. The individual beads were combined to make up the three 
serotyping assays by adding equal volumes of each bead into an amber microcentrifuge 
tube (Diagger, Vernon Hills, IL). Five bead sets were combined to make the O antigen 
assay: Group B; Group C1; Group C2, Group D and Group E. The H antigen assay 
contained 36 bead sets: a; b; c; d; e,h; i; k; r; y; z; z6; z10; z29; and z35; 5 H complex 
antigens: G; EN; 1; L; and Z4; and 16 single factor antigens: 2; 5; 6; 7; f; m(g,m); m(m,t); 
p; s; t(m,t); v;  x; z15; z24; ; z28; and z51. The AT assay was comprised of 3 different 
bead sets: one probe targeting the sdf gene, which is unique to Salmonella serovar 
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Enteritidis; a probe that targeted part of the fljB gene to identify diphasic Salmonella; and 
a probe that detects sequences encoding of the Vi antigen, viaB, in Salmonella serovar 
Typhi.  
Hybridization buffer was prepared fresh each day by diluting each of the bead sets into 
1.5X TMAC buffer (tetramethylammonium chloride, Sigma-Aldrich, St. Louis, MO) to 
yield 2,500 microspheres of each antigen per mL. For each assay, 33 µL of hybridization 
buffer was added to 5 µL of PCR product and 12 µL of TE buffer (Tris-EDTA, pH 8.0, 
Sigma-Aldrich, St. Louis, MO) in an unskirted, 96-well low profile PCR plate (Bio-Rad, 
Hercules, CA). The products were heated to 94°C for 5 minutes, and then held at 52°C 
for 30 minutes for DNA denaturation. Fresh detection buffer was made by diluting SAPE 
(Streptavidin, R-Phycoerythrin conjugate, Invitrogen, Bethesda, MD) in 1X TMAC to a 
final dilution of 4 µg/mL.  Detection buffer (75 µL) was added to the hybridization mix, 
and the samples were moved to a brass plate that was pre-heated to 52°C, and incubated 
(52°C for 10 minutes), in the Bio-Plex 200 Suspension Array instrument (Bio-Rad, 
Hercules, CA). Samples were analyzed for the mean fluorescence intensity (MFI) of each 
bead set and evaluated with comparison to the background fluorescence. In general, a 
positive signal was observed to be greater or equal to 1000; however, there was some 
variance in individual probes.  
Data interpretation.  Results of all three methods were evaluated and placed into one of 
three possible categories: correct, inconclusive, or incorrect. A distinction was made 
between results that were considered to be inconclusive versus results that were incorrect. 
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In the laboratory setting, additional testing will be required prior to reporting of results to 
the customer.  
For classical serotyping and the xMAP Salmonella serotyping assay, results were 
considered correct when both the O and H antigens were identified completely in 
accordance with the Kauffmann-White scheme and matched the expected results. Results 
were considered incomplete when either the O, H1 or H2 antigens, or any combination of 
those antigens were not detected. Results were considered incorrect when the O, H1 or 
H2 antigens or any combination of those antigens did not match expected results and 
differed from the other two tests. 
For the PremiTest assay, results were scored as correct when the named serovar matched 
the expected results based on classical typing. Results were regarded as inconclusive 
when two or more serovar names or codes were given, or when the results were listed as 
“DNA not OK” or “Salmonella species”. Results were considered to be incorrect if the 
identified serovar did not match the expected results and differed from the other two 
tests.  
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CHAPTER 4. RESULTS 
Evaluation of classical Salmonella serotyping.  A total of 233 isolates of Salmonella 
were initially screened (Tables 1 and 2).  Of these, 212 isolates (91%) had complete and 
correct serovar results with Salmonella O and H antisera (Table 1). Nineteen isolates 
(19/233, 8%) were untypeable by classical serology due to a rough O reaction, poor or 
non-motile H antigen, or because the isolate contained multiple serovars, indicating 
mixed cultures (Table 2). NVSL does not routinely provide serovar information on 
samples that are received that do not contain a single isolated colony of Salmonella. Of 
those which could be typed, an overall error rate of less than 1 % (2/233 isolates) was 
achieved with classical typing.  Two isolates were incorrectly serotyped. One sample 
characterized as Salmonella serovar Thompson via the PTS and xMAP Salmonella assay 
had been incorrectly identified as Salmonella serovar Choleraesuis var. Kunzendorf via 
classical typing. Classic typing also designated one sample as Salmonella serovar 
Typhimurium, however, both molecular assays indicated that the isolate was Salmonella 
serovar Saintpaul. Ninety-eight isolates were identified that represented the top ten 
serovars that were observed at the NVSL over the last decade (Table 3). 
Evaluation of the PremiTest Salmonella assay.  A total of 233 isolates of Salmonella 
were tested on the PremiTest assay (Tables 1 and 2). Of these, 150 isolates (64%) had 
complete and correct serovar results. Sixty-four isolates (28%) did not have definitive 
results; 16 listed dual serovars, 33 isolates had results of a unique genovar code, 9 
isolates were listed as Salmonella species, and 6 isolates showed assay failures. An 
overall error rate of 8 % (19/233 isolates) was obtained via testing with the PTS. Of the 
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19 isolates that were incorrectly typed, nine were not covered in the assay and were not 
expected to produce a serovar name [9]. Salmonella serovar Abetetuba was incorrectly 
identified as Salmonella serovar Carrau. Salmonella serovar Istanbul was identified as 
Salmonella serovar Hadar. Salmonella serovar Krefeld was identified as Salmonella 
serovar Gloucester. Two isolates of Salmonella serovar Johannesburg were both 
identified as Salmonella serovar Urbana, and four different serovars were all incorrectly 
identified as Salmonella serovar Senftenberg: Salmonella serovar Uganda, Salmonella 
serovar Apapa, Salmonella serovar Inverness, and Salmonella serovar Putten. Ten 
additional isolates that were identified incorrectly on the PremiTest were expected to be 
correctly typed on the basis of assay coverage [9]. These included two isolates of 
Salmonella serovar Anatum which were incorrectly typed as Salmonella serovar Newport 
or Oranienburg and Salmonella serovar Brandenburg. One isolate each of Salmonella 
serovar Kentucky and Salmonella serovar Give were identified as Salmonella serovar 
Manchester. Salmonella serovar Dublin was identified as Salmonella serovar Manhattan, 
Salmonella serovar Orion was identified as Salmonella serovar Livingstone, Salmonella 
serovar Senftenberg was identified as Salmonella serovar Newport, Salmonella serovar 
was identified as Salmonella serovar Schwarzengrund or Grumpensis, and two isolates of 
Salmonella serovar Schwarzengrund were identified incorrectly. The first was identified 
as Salmonella serovar Poona and the second was identified as Salmonella serovar Altona. 
When only the 98 isolates that represent the top ten serovars observed at the NVSL over 
the last decade are considered (Table 3), the PTS correctly identified 87 (89%), 7 isolates 
were inconclusive (7%) and 4 isolates (4%) were incorrectly identified as a different 
serovar.  
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Evaluation of the xMAP Salmonella serotyping assay.  A total of 233 isolates of 
Salmonella were analyzed on the xMAP assay (Tables 1 and 2). Of these, 181 isolates 
(78%) had complete and correct serovar results with Salmonella O and H microspheres. 
Fifty isolates (21%) did not have complete serovar information given on the xMAP 
assay; 11 isolates did not have an O antigen determined, 24 isolates were missing an H 
antigen, and 15 isolates were missing both O and H antigens. An overall error rate of less 
than 1 % (2/233 isolates) was obtained via testing with the xMAP assay. Two isolates 
were typed incorrectly on the xMAP assay. One isolate of Salmonella serovar Dublin was 
incompletely typed on the xMAP. Salmonella serovar Dublin is an O group D, and is a 
monophasic culture with g,p as the H1 antigen: (D:g,p:-). The antigenic formula on the 
xMAP for this isolate was E:L complex,-:1,5. The second isolate that was incorrectly 
typed was Salmonella serovar Fresno, which is also a monophasic culture. The O group is 
D, and the H1 antigen is z38, which is not an available bead on the assay: (D:z38:-). On 
the xMAP assay, the isolate showed O group D and H1 as the Z4 complex. When 
considering only the 98 isolates that represent the top ten serovars observed at the NVSL 
over the last decade (Table 3), the xMAP assay correctly identified 86 (88%), 12 isolates 
(12%) of Salmonella serovar Senftenberg were not completely typed. There were no 
isolates incorrectly typed.  
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CHAPTER 5. DISCUSSION 
Classical serotyping has been an invaluable tool for characterizing Salmonella for 
surveillance and epidemiology; however, it does have its limitations. Obtaining serovar 
identification is dependent upon the phenotypic expression of surface antigens. When 
these antigens are incompletely expressed, definitive serovar identification cannot be 
achieved. DNA based assays such as the PTS and the xMAP are able to overcome these 
obstacles by identifying the genes that are responsible for encoding these antigens. 
This study highlighted a few of the weaknesses of classical serotyping. One of the 
problems that can be encountered is the variability in the expression of the flagellar 
antigens. One serovar was incorrectly identified as Salmonella serovar Choleraesuis var. 
Kunzendorf. It has been suggested that this serovar does not always exhibit the first phase 
H (H1) antigen [3].  Because of this known aberration, if the H1 antigen is absent, but the 
remaining antigens and biochemical reactions are correct, and the isolate is of swine 
origin, the isolate is designated as Salmonella serovar Choleraesuis var. Kunzendorf.  
This isolate met the above criteria: it was of swine origin, the O antigen and the second 
phase H antigen, and the biochemical profile matched that of Salmonella serovar 
Choleraesuis var. Kunzendorf. However, the H1 antigen was absent.  Further analysis by 
molecular typing on both the PTS and the xMAP assays showed that the antigenic 
composition of the isolate matched that of Salmonella serovar Thompson. Serological 
testing was repeated and the results were consistent with the original results. It is believed 
that the molecular assays were correct and that the unexpressed first phase H antigen was 
a “k” as opposed to that of Salmonella serovar Choleraesuis, which, when expressed, 
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would be “c.” NVSL has since changed its policy and will no longer assign a serovar 
name to an isolate that is missing components of the antigenic structure when testing by 
classical serotyping. A second isolate was incorrectly typed as Salmonella serovar 
Typhimurium. Molecular analysis via the PTS and the xMAP assays indicated that the 
sample was Salmonella serovar Saintpaul. Serological testing was repeated and also 
confirmed that the isolate was Salmonella serovar Saintpaul. An overall error rate of less 
than 1 % (2/233 isolates) was achieved with classical typing. Nineteen isolates (8%) were 
considered to be untypeable by classical serotyping due to rough O antigens or lack of 
expression of one or both H antigens. Analysis by the two molecular assays gave new 
insight into three of these isolates. One of the two samples that were identified as 
4,(5),12:r:- through classical serotyping had the same results on the xMAP assay, and the 
marker for the fljB gene was also negative, indicating that the gene for the second phase 
H antigen was incomplete or missing. The PTS identified this isolate as Salmonella 
serovar Heidelberg. The PTS does not have a name built into the database for this 
serovar; however, the results given are not entirely inconsistent with the results obtained 
from the other two tests. One of the three samples that were classically serotyped as 
4,(5),12:i:- had the exact same results on the PTS and the xMAP assays. This serovar, 
although not named, is accounted for on the PTS. The second of the three showed the 
same results on classical serotyping and the xMAP, and the marker for the fljB gene was 
also negative, however, the PTS identified the isolate as Salmonella serovar 
Typhimurium. Again, this identification is not completely inconsistent with the other two 
tests. Results for the remaining 16 isolates that were considered incomplete with classical 
serotyping were consistent with the serovars that were identified with molecular typing.  
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Of the top ten serotypes received at the NVSL, the PTS was able to successfully identify 
89% of the isolates. Seven percent were inconclusive and four percent were incorrect. 
However, when looking at a wider variety of isolates, the PTS was able to successfully 
type 64% of the isolates.  Sixty-four total isolates (27%) had inconclusive results on the 
PTS. Of these, there were five different serovars that had multiple isolates tested which 
gave unique genovar codes for at least two isolates in the set. Two isolates of Salmonella 
serovar Alachua were given the genovar 4212. Three isolates of Salmonella serovar Give 
were tested. Two isolates gave the unique genovar code of 14399, and one isolate was 
incorrectly named Salmonella serovar Manchester. Three isolates of Salmonella serovar 
Uganda were tested. Two of the three gave the unique genovar code 13487, and one 
isolate was given an incorrect name, Salmonella serovar Senftenberg. Of six isolates of 
Salmonella serovar Worthington, three isolates were given the correct serovar name, and 
three isolates gave the unique genovar code of 14369. Eleven isolates of Salmonella 
serovar Kentucky, along with two isolates that were incompletely typed by classical 
serology as rough O:i:z6 and 8,(20):-:z6 that were confirmed as Salmonella serovar 
Kentucky on the xMAP assay were tested. Four isolates were correctly identified, six 
isolates were given the unique genovar of 10299 and two other isolates were given the 
unique genovar of 10283. One isolate had results that gave three different possibilities; 
Salmonella serovar Manchester, genovar 10299 and genovar 10283. Additional testing on 
these serovars to ensure consistent results could allow the manufacturer to add them to 
the database. If these codes had been included in the database, the PTS would have 
identified 17 additional isolates bringing the total of complete results to 167 (72%). There 
was another interesting observation with the PTS assay. As stated previously, when 
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multiple isolates of the same serovar were chosen, great care was taken to select those 
that represented unique strains among the same serovar by picking isolates that were 
from different species, different time periods, and/or from different locations. The 
incomplete or incorrect results were not evenly distributed among all of the serotypes, 
rather, the PTS was able to completely identify all isolates of some serovars, and able to 
identify only a few isolates of other serovars. There were 13 different serovars that had 
multiple isolates tested that the PTS was not able to identify. Three of those, Salmonella 
serovars Give, Kentucky and Worthington were previously discussed, as the PTS gave 
consistent unique genovar codes to isolates in those groups. Ten additional serovar sets 
also proved problematic. Six isolates of Salmonella serovar Anatum were tested, four 
isolates were correctly identified, and two isolates were incorrectly named Salmonella 
serovar Newport or Orainienburg and Salmonella serovar Brandenburg. Five isolates of 
Salmonella serovar Braenderup were tested; three were correctly identified, one isolate 
was given a unique genovar code and one isolate was reported as Salmonella suspected. 
Five isolates of Salmonella serovar Cerro were tested, with three correctly named, one 
reported as 4,(5),12:i:- or Salmonella serovar Cerro, and one reported as Salmonella 
serovar Senftenberg or Salmonella serovar Cerro. Four isolates of Salmonella serovar 
Choleraesuis were tested. Two isolates were reported as Salmonella serovar Choleraesuis 
or Salmonella serovar Paratyphi, one isolate was reported as “DNA not OK”, and one 
isolate was reported as serotype not determined. Seven isolates of Salmonella serovar 
Dublin were tested. Four isolates were correctly identified, one isolate was given a 
unique genovar code, one isolate was identified as Salmonella serovar Banana or 
Salmonella serovar Dublin and one isolate was incorrectly named Salmonella serovar 
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Manhattan. Four isolates of Salmonella serovar Meleagridis were tested. Two isolates 
were correctly identified, one isolate was given a unique genovar code, and one isolate 
was incorrectly identified as Salmonella serovar Schwarzengrund or Salmonella serovar 
Grumpensis. Eight isolates of Salmonella serovar Muenster were tested. Six isolates were 
identified as Salmonella serovar Munster or Salmonella serovar Reading, one isolate was 
reported as “DNA not OK” and one isolate was reported as Salmonella species. Three 
isolates of Salmonella serovar Orion were tested. One isolate was incorrectly identified as 
Salmonella serovar Livingstone, and two isolates were reported as DNA not OK. Five 
isolates of Salmonella serovar Schwarzengrund were tested. Three isolates were 
identified as Salmonella serovar Schwarzengrund or Salmonella serovar Grumpensis, and 
two isolates were incorrectly named. One isolate was identified as Salmonella serovar 
Poona and the other was identified as Salmonella serovar Altona. Two isolates of 
Salmonella serovar Johannesburg, which were not on the list of serovars that were 
covered on the PTS assay, were incorrectly identified as Salmonella serovar Urbana. 
Incorrect results were given for 19 isolates on the PTS. Of these, nine isolates were not 
expected to give a serovar result due to non-coverage on the assay. Ten more isolates 
were expected to be correctly typed.  
The European-based PTS offers a new multiplex format for rapid identification of 
Salmonella serovars that is based on genetic markers and not phenotypic expression. Test 
time required from recovery of a single colony until the isolate is identified in 
approximately eight hours, which has significant advantages over the three or more days 
required for classical serotyping. The PTS equipment has a small footprint and could 
39 
 
easily be incorporated into any laboratory that does serotyping. As more isolates are 
tested, information could be added to the PTS database and released as simple software 
updates. There are some issues that need to be addressed by the manufacturer, however. 
The current price of approximately $44 per isolate will significantly limit the number of 
laboratories that will be able to afford the technology. Although the PTS did well at 
identifying 89% of the top ten serotypes, it had a four percent error rate on those isolates 
as well. When all 233 isolates representing more than 52 serovars were considered, the 
PTS was able to identify just 64% of the isolates correctly, and it had an error rate of nine 
percent. Based on these results, a reference laboratory that receives a wide variety of 
isolates may find the specificity of the assay to be problematic. Finally, there were a few 
issues with the timing of the final staining step and the subsequent analysis by the ATR. 
The manufacturer indicates that the array tube must be read 15 minutes after staining. 
This presented a logistical problem if several isolates were tested at the same time, which 
is one of the advantages of such an assay. Immediately before the array tube could be 
read, a unique 11 digit code had to be entered into the software for each of the three 
isolates in the tube. If 21 isolates (7 array tubes) were being tested at a time, more than 20 
minutes had passed before the last array tube could be read. Changing the software to 
allow for the entering of sample information prior to running the assay would resolve this 
issue. There was also significant variability in the timing of the analysis that could not be 
traced to any specific serovar or other circumstance. There would be occasions where at 
15 minutes, the stain in the array tube was not developed and results could not be 
determined. Re-analyzing after 25 minutes would then yield a serovar result. On other 
occasions, the array tube would be over-stained at 15 minutes, and results would not be 
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obtained. Following this observation, tubes were analyzed at both 15 and 25 minutes for 
the remainder of the project. This did resolve some issues, however, there were times 
when the 15 minute read would provide one serovar name, and the 25 minute read would 
provide a different serovar name. It was decided that, in this project, the first serovar 
name that was given would be accepted as the serovar name upon which results would be 
based, as this was in accordance with the manufacturer’s directions. The assay, at tested 
conditions, is a rapid screening tool that provides valuable information about the samples 
being tested. Serovar identification should be confirmed using the data provided by the 
PTS either in-house or through a diagnostic reference laboratory. 
When considering the top ten serovars received by the NVSL, the xMAP assay was able 
to successfully type 88% of the isolates. Twelve percent were partially typed, and there 
were no incorrect results. The xMAP was able to completely type 78% of all 233 isolates 
tested and 21% of all isolates had partial results. Two isolates, Salmonella serovar Dublin 
and Salmonella serovar Fresno gave unexpected results. The expected results of 
Salmonella serovar Dublin were D:g,p:-, however the actual results on the xMAP were 
E:L complex,-:1,5. The PTS and classical serotyping both indicated that the isolate was 
Salmonella serovar Dublin. Additional testing was not an option due to loss of viability 
of the isolate. The possibility of cross contamination was considered, but there were no 
other isolates that were tested at that time with antigens similar to the results obtained. 
The expected results for Salmonella serovar Fresno on the xMAP are D:-:-, as the z38 
antigen is not included in the assay. The actual results that were observed on the xMAP 
were D:Zcomplex,-:-. This isolate was not included in the PTS database, and it was 
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identified with a unique genovar code. Retesting with classical typing agreed with the 
original results. Five isolates, Salmonella serovar Abetetuba, Salmonella serovar 
Barranquilla, Salmonella serovar Cubana, Salmonella serovar Mississippi and Salmonella 
serovar Rubislaw, were incompletely typed on the xMAP assay, due to non-coverage of 
their O antigens. Updates to the assay have been made since testing, and these isolates 
can now be completely typed on the xMAP.  Based on the O and H beads that were 
included in the assay at the time of testing, 181 of the 233 isolates were predicted to give 
complete serovar identification (Table 4). The xMAP had complete coverage of 90% of 
these isolates. One isolate of Salmonella serovar Dublin that was expected to be correctly 
identified gave incorrect results. All 12 isolates of Salmonella serovar Senftenberg were 
incompletely typed. The expected results for this were E:g,s,t:-, however, the actual 
results for all isolates were E:g,s:-. The xMAP assay does have a bead representing single 
factor “t”, but, this antigen is known to have 3 lineages, and the “t” bead in the assay does 
not currently represent all lineages [39, 50]. Salmonella serovar Taksony had expected 
results of E:i:z6 on the xMAP assay, however, the actual results were -:i:z6. Additional 
isolates were not tested, so, it is not known if this is a problem with the serovar or if it 
was related to the actual isolate tested. Classical serotyping was repeated and the results 
were consistent with original testing. Salmonella serovar Muenster did not produce 
consistent results on the xMAP assay. The expected results were E:e,h:1,5. The actual 
results from four isolates was E:e,h:1,-. The other four isolates were identified as 
E:e,h:1,5, although results from the single factor “5” bead were weaker than other 
serovars expressing single factor “5”. Salmonella serovar Munster is known to variably 
express the antigen for single factor five, which is not considered to be of 
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epidemiological significance [50]. In total, 11 isolates were missing O antigen results, 24 
isolates were missing an H antigen result, and 15 isolates were missing both an O and H 
antigen result due to lack of coverage of the antigens on the assay.  
The xMAP offers a rapid molecular alternative to classical serotyping in a 96-well 
multiplex format. Typing time is approximately five hours from a single colony. The 
xMAP assay considers the O and H antigens on a molecular level, and is not constrained 
to the vagaries of phenotypic expression that occur with classical serotyping. The assay is 
relatively simple to perform and the results are easily interpreted. The price is 
approximately $10-$15 per isolate, which will allow many laboratories to utilize it. 
Finally, the biggest advantage of the xMAP assay is the ability to obtain partial serovar 
information. Because the results are based on the O and H antigens, information obtained 
can be compared against the Kauffmann-White scheme and the isolate tested only for the 
remaining antigens. Incorporating the results from the xMAP into classical serotyping 
shortens the necessary time to type, decreases the amount of antisera that is required to 
test and potentially eliminates the need to perform phase inversion on an isolate. 
Although the xMAP was not able to completely identify all 233 isolates that were tested, 
with the exception of the one isolate of Salmonella serovar Dublin which had incorrect 
results for both the O and H antigens, the assay provided correct information for at least 
part of each isolate tested. Future development of beads targeting additional O and H 
antigens can easily be incorporated into the assay. The issues of the xMAP not detecting 
some of the single factors that appear to be present in the assay have been previously 
noted by McQuiston and Fitzgerald. Future releases may contain beads that better 
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represent these isolates. The xMAP Salmonella assay provides a relatively inexpensive 
alternative to classical serotyping for many laboratories that are testing the most common 
serotypes. Time to test from an isolated colony is about five hours as opposed to the 
several days necessary for classical serotyping. If complete information for a serovar is 
not obtained, testing needs to be performed for only the missing antigens. The error rate 
for the xMAP is less than one percent, which is comparable to that observed with 
classical serotyping. As developed, the xMAP assay can be used as a complement to 
classical typing; however, it will not replace the need for additional antisera, as there are 
many isolates of significance to both human and animal health which do not yet have 
complete serovar coverage. 
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Table 1. Results of serovars tested by method 
  Kauffmann-White PremiTest Salmonella xMAP Salmonella 
Serovar Number 
of  
samples 
Correct 
serovar 
Inconclusive 
serovar 
Wrong 
serovar 
Correct 
serovar 
Inconclusive 
serovar  
Wrong 
serovar 
Correct 
serovar 
Inconclusive 
serovar 
Wrong 
serovar 
           
Abetetuba 1 1 0 0 0 0 1 0 1a 0 
Agona  9 9 0 0 9 0 0 9 0 0 
Alabama 1 1 0 0 0 1 0 1 0 0 
Alachua 2 2 0 0 0 2 0 0 2 0 
Albert 1 1 0 0 0 1 0 1 0 0 
Altona 2 2 0 0 2 0 0 2 0 0 
Amager 1 1 0 0 0 1 0 1 0 0 
Anatum 6 6 0 0 4 0 2 6 0 0 
Apapa 1 1 0 0 0 0 1 0 1 0 
Barranquila 1 1 0 0 0 1 0 0 1a 0 
Berta 1 1 0 0 1 0 0 1 0 0 
Braenderup 5 5 0 0 3 2 0 5 0 0 
Bredeney 1 1 0 0 1 0 0 1 0 0 
Cerro 5 5 0 0 3 2 0 0 5 0 
Cholerasuis  4 4 0 0 0 4 0 4 0 0 
Cubana 1 1 0 0 1 0 0 0 1 a 0 
Derby 5 5 0 0 5 0 0 5 0 0 
Dublin 10 10 0 0 7 2 1 9 0 1 
Enteritidis 13 13 0 0 13 0 0 13 0 0 
Fresno 1 1 0 0 0 1 0 0 0 1 
Gallinarum 2 2 0 0 2 0 0 2 0 0 
Gaminara 1 1 0 0 0 1 0 0 1 0 
Give 3 3 0 0 0 2 1 3 0 0 
Hadar 10 10 0 0 9 1 0 10 0 0 
Heidelberg 11 11 0 0 11 0 0 11 0 0 
Infantis 5 5 0 0 5 0 0 5 0 0 
Inverness 1 1 0 0 0 0 1 0 1 0 
 
 
 
aAdditional O beads were not available for complete serotyping of these isolates at the time of the study, 
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Table 1. Continued 
Istanbul 1 1 0 0 0 0 1 1 0 0 
Johannesburg 2 2 0 0 0 0 2 0 2 0 
Kentucky 11 11 0 0 4 6 1 11 0 0 
Kiambu 1 1 0 0 0 1 0 1 0 0 
Krefeld 1 1 0 0 0 0 1 0 1 0 
London 2 2 0 0 2 0 0 2 0 0 
Mbandaka 5 5 0 0 5 0 0 5 0 0 
Meleagridis 4 4 0 0 2 1 1 0 4 0 
Mississippi 1 1 0 0 0 1 0 0 1 a 0 
Montevideo 10 10 0 0 10 0 0 10 0 0 
Muenchen 1 1 0 0 1 0 0 1 0 0 
Munster 8 8 0 0 0 8 0 4 4 0 
Newport 10 10 0 0 9 1 0 10 0 0 
Norwich 1 1 0 0 0 1 0 1 0 0 
Orion 3 3 0 0 0 2 1 3 0 0 
Ouakam 1 1 0 0 1 0 0 1 0 0 
Pullorum 5 5 0 0 4 1 0 5 0 0 
Putten 1 1 0 0 0 0 1 0 1 0 
Rubislaw 1 1 0 0 0 1 0 0 1a 0 
Saintpaul 1 0 0 1 1 0 0 1 0 0 
Schwarzengrund 5 5 0 0 0 3 2 5 0 0 
Senftenberg 12 12 0 0 11 0 1 0 12 0 
Soerenga 1 1 0 0 0 1 0 0 1 0 
Taksony 1 1 0 0 0 1 0 0 1 0 
Thompson 1 0 0 1 1 0 0 1 0 0 
Typhimurium 11 11 0 0 11 0 0 11 0 0 
Uganda 3 3 0 0 0 2 1 0 3 0 
Worthington 6 6 0 0 3 3 0 0 6 0 
TOTALS  
214 
212 
(99%) 
0 
(0%) 
2 
(1%) 
141 
(66%) 
54 
(25%) 
19 
(9%) 
162 
(76%) 
50 
(23%) 
2 
(1%) 
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Table 2. Results of PremiTest Salmonella and xMAP Salmonella on classically untypeable strains 
  PremiTest Salmonella xMAP Salmonella 
Serovar Number of Samples Correct 
serovar 
Inconclusive 
serovar 
Correct 
serovar 
Inconclusive 
serovar 
3,15:e,h:- 1 0 1 1 0 
4,(5),12:r:- 2 1 1 2 0 
4,5,12:i:- 3 2 1 3 0 
4,5,12:Non-motile 1 0 1 1 0 
8,(20):-:z6 1 0 1 1 0 
9,12:Non-motile 3 3 0 3 0 
Kentucky & Heidelberg 1 0 1a 1 0 
Rough O:f,g,s:- 2 2 0 2 0 
Rough O:g,p 1 0 1 1 0 
Rough O:i:1,2 1 0 1 1 0 
Rough O:i:z6 1 0 1 1 0 
Rough O:k:1,5 1 1 0 1 0 
Rough O:r:1,2 1 0 1 1 0 
Total 19 9 (47%) 10 (53%) 19(100%) 0 
aSubmitted culture contained two serovars 
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Table 3. Results by method of the top ten serovars received at the National Veterinary Services Laboratories 
  Kauffmann-White Premitest Salmonella xMAP Salmonella 
Serovar Number 
of 
Samples 
Correct 
serovar 
Inconclusive 
serovar 
Wrong 
serovar 
Correct 
serovar 
Inconclusive 
serovar 
Wrong 
serovar 
Correct 
serovar 
Inconclusive 
serovar 
Wrong 
serovar 
Typhimurium 11 11 0 0 11 0 0 11 0 0 
Heidelberg 11 11 0 0 11 0 0 11 0 0 
Newport 10 10 0 0 9 1 0 10 0 0 
Kentucky 11 11 0 0 4 6 1 11 0 0 
Senftenberg 12 12 0 0 11 0 1 0 12 0 
Enteritidis 13 13 0 0 13 0 0 13 0 0 
Montevideo 10 10 0 0 10 0 0 10 0 0 
Derby 5 5 0 0 5 0 0 5 0 0 
Agona 9 9 0 0 9 0 0 9 0 0 
Anatum 6 6 0 0 4 0 2 6 0 0 
TOTAL 98 98 
(100%) 
0 
(0%) 
0 
(0%) 
87 
(89%) 
7 
(7%) 
4 
(4%) 
86 
(88%) 
12 
(12%) 
0 
(0%) 
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Table 4. Predicted versus actual identification of serovars tested by molecular assay 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                               PremiTest Salmonella xMAP Salmonella 
Serovar Number of 
Samples 
Predicted correct Actual correct Predicted correct Actual correct 
Abetetuba 1 0 0 0 0 
Agona  9 9 9 9 9 
Alabama 1 0 0 1 1 
Alachua 2 0 0 0 0 
Albert 1 0 0 1 1 
Altona 2 2 2 2 2 
Amager 1 0 0 1 1 
Anatum 6 6 4 6 6 
Apapa 1 0 0 0 0 
Barranquila 1 0 0 0 0 
Berta 1 1 1 1 1 
Braenderup 5 5 3 5 5 
Bredeney 1 1 1 1 1 
Cerro 5 5 3 0 0 
Cholerasuis var 
Kunzendorf 
4 4 0 4 4 
Cubana 1 1 1 0 0 
Derby 5 5 5 5 5 
Dublin 10 10 7 10 9 
Enteritidis 13 13 13 13 13 
Fresno 1 0 0 0 0 
Gallinarum 2 2 2 2 2 
Gaminara 1 0 0 1 1 
Give 3 3 0 3 3 
Hadar 10 10 9 10 10 
Heidelberg 11 11 11 11 11 
Infantis 5 5 5 5 5 
Inverness 1 0 0 0 0 
Istanbul 1 0 0 1 1 
Johannesburg 2 0 0 0 0 
Kentucky 11 11 4 11 11 
Kiambu 1 0 0 1 1 
Krefeld 1 0 0 0 0 
London 2 2 2 2 2 
Mbandaka 5 5 5 5 5 
Meleagridis 4 4 2 0 0 
Mississippi 1 0 0 0 0 
Montevideo 10 10 10 10 10 
Muenchen 1 1 1 1 1 
Munster 8 8 0 8 4 
Newport 10 10 9 10 10 
Norwich 1 0 0 1 1 
Orion 3 3 0 3 3 
Ouakam 1 1 1 1 1 
Pullorum 5 5 4 5 5 
Putten 1 0 0 0 0 
Rubislaw 1 0 0 0 0 
Saintpaul 1 1 1 1 1 
Schwarzengrund 5 5 0 5 5 
Senftenberg 12 12 11 12 0 
Soerenga 1 0 0 0 0 
Taksony 1 0 0 1 0 
Thompson 1 1 1 1 1 
Typhimurium 11 11 11 11 11 
Uganda 3 0 0 0 0 
Worthington 6 6 3 0 0 
TOTALS 214 189 141 
(75%) 
181 163 
(90%) 
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